National Bank of Canada’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5K Sell
5,335
-7,479
-58% -$17.5K ﹤0.01% 2323
2025
Q4
$34.6K Buy
12,814
+1,961
+18% +$6.44K ﹤0.01% 2039
2025
Q3
$45.8K Buy
10,853
+1,075
+11% +$4.73K ﹤0.01% 1961
2025
Q2
$48.7K Buy
9,778
+274
+3% +$1.19K ﹤0.01% 1966
2025
Q1
$41.9K Buy
9,504
+1,196
+14% +$5.61K ﹤0.01% 1919
2024
Q4
$38.6K Buy
8,308
+2,151
+35% +$11.8K ﹤0.01% 2022
2024
Q3
$42.7K Sell
6,157
-602
-9% -$4.72K ﹤0.01% 1759
2024
Q2
$52.6K Sell
6,759
-127
-2% -$941 ﹤0.01% 1672
2024
Q1
$45.4K Buy
6,886
+594
+9% +$3.93K ﹤0.01% 1787
2023
Q4
$35.2K Buy
6,292
+710
+13% +$4K ﹤0.01% 1876
2023
Q3
$30.8K Buy
5,582
+680
+14% +$4.53K ﹤0.01% 1932
2023
Q2
$27K Buy
4,902
+3,307
+207% +$17.8K ﹤0.01% 1936
2023
Q1
$9.96K Buy
1,595
+1,128
+242% +$6.29K ﹤0.01% 2140
2022
Q4
$2.17K Buy
+467
New +$2.3K ﹤0.01% 2474
2022
Q1
Sell
-30,100
Closed -$984K 2911
2021
Q4
$984K Buy
+30,100
New +$1.21M ﹤0.01% 1059

Other funds holding GDRX

National Bank of Canada's GDRX Position: Q1 2026 in Review

National Bank of Canada reduced its GoodRx Holdings (GDRX) stake by 58% in Q1 2026, selling an estimated $17.5K and leaving 5,335 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

National Bank of Canada first reported a position in GDRX in Q4 2021 and has held it in 15 quarters since. The position peaked at $984K in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • National Bank of Canada held 5,335 shares of GoodRx Holdings worth $10.5K as of Q1 2026.
  • National Bank of Canada sold 7,479 GoodRx Holdings shares in Q1 2026, an estimated $17.5K.
  • GoodRx Holdings made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2323 holding.
  • National Bank of Canada first reported a position in GoodRx Holdings in Q4 2021 and has held it in 15 quarters since.
  • National Bank of Canada's GoodRx Holdings position peaked at $984K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.